NEWS RELEASE: Watson-Marlow to demonstrate fluid path product range at INTERPHEX 2023

Watson-Marlow Fluid Technology Solutions (WMFTS) will showcase its diverse fluid path product range at booth 3258 during INTERPHEX 2023 in New York City, from April 25-27.

WMFTS will demonstrate its precision-engineered peristaltic pumps and critical fluid path technologies for scalable drug substance bioprocess and small-batch drug product fill/finish applications.

Visitors to the WMFTS booth can learn how fluid path technology provides flow accuracy, ensures process stability, good manufacturing practice (GMP) compliance and final product quality.

Showcased products include the Flexicon PF7+, a benchtop peristaltic dispensing pump developed for accurate and reliable manual filling of sensitive fluids in GMP production and cleanroom environments. Also on display will be the full range of Watson-Marlow cased peristaltic pumps, puresu® single-use assemblies, ASEPCO® diaphragm valves for aseptic processing and high-purity Aflex PTFE flexible hoses with best-in-class kink resistance for the most challenging applications.

Alex Page of WMFTS said: “We look forward to showcasing our latest innovations in fluid path technology and continuing to collaborate with our customers on developing the next generation of solutions for an ever-evolving Life Sciences industry.”

WMFTS’s comprehensive portfolio of products and assembly design capabilities can support customers’ processes throughout upstream, downstream and final fill/finish applications. Research laboratories through to bulk drug substance GMP facilities choose to partner with WMFTS due to its ability to continuously reduce risk by providing reliable control over their fluid path process.

Visit the WMFTS booth to see how the company can work with you at every process step and support the advancement of your bioprocess from end to end.

About Watson-Marlow Fluid Technology Solutions

Watson-Marlow Fluid Technology Solutions (WMFTS) is a world leader in manufacturing niche peristaltic pumps and associated fluid path technologies for the life sciences and process industries. WMFTS is a wholly owned subsidiary of Spirax-Sarco Engineering plc and is headquartered in Cornwall, England, with operations in 43 countries. Further information can be found at www.wmfts.com.

The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.